A Detailed Analysis of the Cardiac Biomarker Diagnostic Test Kits Market Based on Rapid Advancements in Point of Care Technology, Increasing Prevalence of CVDs, and Expanding Aging Population Worldwide
Industry: Healthcare
Published Date: January-2024
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 209
Report ID: PMRREP33704
Table of Contents
1. Executive Summary
1.1. Global Cardiac Biomarker Diagnostic Test Kits Market Snapshot, 2023 and 2030
1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Product Type Lifecycle Analysis
2.4. Cardiac Biomarker Diagnostic Test Kits Market: Value Chain
2.4.1. List of Raw Material Supplier
2.4.2. List of Manufacturers
2.4.3. List of Distributors
2.4.4. List of Applications
2.4.5. Profitability Analysis
2.5. Porter Five Force's Analysis
2.6. Geopolitical Tensions: Market Impact
2.7. Macro-Economic Factors
2.7.1. Global Sectorial Outlook
2.7.2. Global GDP Growth Outlook
2.7.3. Global Parent Market Overview
2.8. Forecast Factors - Relevance and Impact
2.9. Regulatory and Technology Landscape
3. Global Cardiac Biomarker Diagnostic Test Kits Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
3.1. Key Highlights
3.1.1. Market Volume (Units) Projections
3.1.2. Market Size and Y-o-Y Growth
3.1.3. Absolute $ Opportunity
3.2. Market Size (US$ Mn) Analysis and Forecast
3.2.1. Historical Market Size Analysis, 2013-2016
3.2.2. Current Market Size Forecast, 2018-2026
3.3. Global Cardiac Biomarker Diagnostic Test Kits Market Outlook: Product Type
3.3.1. Introduction / Key Findings
3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product Type, 2018 - 2022
3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
3.3.3.1. Brain Natriuretic Peptide (BNPs) Test Kits
3.3.3.2. Creatine Kinase MB (CK-MB) Test Kits
3.3.3.3. Troponin (I&T) Tests Kits
3.3.3.4. Myoglobin Test Kits
3.3.3.5. Others
3.4. Market Attractiveness Analysis: Product Type
3.5. Global Cardiac Biomarker Diagnostic Test Kits Market Outlook: Indication
3.5.1. Introduction / Key Findings
3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Indication, 2018 - 2022
3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Indication, 2023 - 2030
3.5.3.1. Angina Pectoris
3.5.3.2. Acute Myocardial Infarction
3.5.3.3. Congestive Heart Failure
3.5.3.4. Others
3.6. Market Attractiveness Analysis: Indication
3.7. Global Cardiac Biomarker Diagnostic Test Kits Market Outlook: End-Use
3.7.1. Introduction / Key Findings
3.7.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By End-Use, 2018 - 2022
3.7.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By End-Use, 2023 - 2030
3.7.3.1. Hospitals
3.7.3.2. Diagnostic Laboratories
3.7.3.3. Outpatient Clinics
3.7.3.4. Academic & Research Institutes
3.8. Market Attractiveness Analysis: End-Use
4. Global Cardiac Biomarker Diagnostic Test Kits Market Outlook: Region
4.1. Key Highlights
4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022
4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030
4.3.1. North America
4.3.2. Europe
4.3.3. East Asia
4.3.4. South Asia & Pacific
4.3.5. Latin America
4.3.6. Middle East & Africa (MEA)
4.4. Market Attractiveness Analysis: Region
5. North America Cardiac Biomarker Diagnostic Test Kits Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
5.1. Key Highlights
5.2. Pricing Analysis
5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
5.3.1. By Country
5.3.2. By Product Type
5.3.3. By Indication
5.3.4. By End-Use
5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
5.4.1. U.S.
5.4.2. Canada
5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
5.5.1. Brain Natriuretic Peptide (BNPs) Test Kits
5.5.2. Creatine Kinase MB (CK-MB) Test Kits
5.5.3. Troponin (I&T) Tests Kits
5.5.4. Myoglobin Test Kits
5.5.5. Others
5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Indication, 2023 - 2030
5.6.1. Angina Pectoris
5.6.2. Acute Myocardial Infarction
5.6.3. Congestive Heart Failure
5.6.4. Others
5.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End-Use, 2023 - 2030
5.7.1. Hospitals
5.7.2. Diagnostic Laboratories
5.7.3. Outpatient Clinics
5.7.4. Academic & Research Institutes
5.8. Market Attractiveness Analysis
6. Europe Cardiac Biomarker Diagnostic Test Kits Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
6.1. Key Highlights
6.2. Pricing Analysis
6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
6.3.1. By Country
6.3.2. By Product Type
6.3.3. By Indication
6.3.4. By End-Use
6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
6.4.1. Germany
6.4.2. France
6.4.3. U.K.
6.4.4. Italy
6.4.5. Spain
6.4.6. Russia
6.4.7. Turkey
6.4.8. Rest of Europe
6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
6.5.1. Brain Natriuretic Peptide (BNPs) Test Kits
6.5.2. Creatine Kinase MB (CK-MB) Test Kits
6.5.3. Troponin (I&T) Tests Kits
6.5.4. Myoglobin Test Kits
6.5.5. Others
6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Indication, 2023 - 2030
6.6.1. Angina Pectoris
6.6.2. Acute Myocardial Infarction
6.6.3. Congestive Heart Failure
6.6.4. Others
6.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End-Use, 2023 - 2030
6.7.1. Hospitals
6.7.2. Diagnostic Laboratories
6.7.3. Outpatient Clinics
6.7.4. Academic & Research Institutes
6.8. Market Attractiveness Analysis
7. East Asia Cardiac Biomarker Diagnostic Test Kits Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
7.3.1. By Country
7.3.2. By Product Type
7.3.3. By Indication
7.3.4. By End-Use
7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
7.4.1. China
7.4.2. Japan
7.4.3. South Korea
7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
7.5.1. Brain Natriuretic Peptide (BNPs) Test Kits
7.5.2. Creatine Kinase MB (CK-MB) Test Kits
7.5.3. Troponin (I&T) Tests Kits
7.5.4. Myoglobin Test Kits
7.5.5. Others
7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Indication, 2023 - 2030
7.6.1. Angina Pectoris
7.6.2. Acute Myocardial Infarction
7.6.3. Congestive Heart Failure
7.6.4. Others
7.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End-Use, 2023 - 2030
7.7.1. Hospitals
7.7.2. Diagnostic Laboratories
7.7.3. Outpatient Clinics
7.7.4. Academic & Research Institutes
7.8. Market Attractiveness Analysis
8. South Asia & Oceania Cardiac Biomarker Diagnostic Test Kits Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
8.3.1. By Country
8.3.2. By Product Type
8.3.3. By Indication
8.3.4. By End-Use
8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
8.4.1. India
8.4.2. Southeast Asia
8.4.3. ANZ
8.4.4. Rest of South Asia & Oceania
8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
8.5.1. Brain Natriuretic Peptide (BNPs) Test Kits
8.5.2. Creatine Kinase MB (CK-MB) Test Kits
8.5.3. Troponin (I&T) Tests Kits
8.5.4. Myoglobin Test Kits
8.5.5. Others
8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Indication, 2023 - 2030
8.6.1. Angina Pectoris
8.6.2. Acute Myocardial Infarction
8.6.3. Congestive Heart Failure
8.6.4. Others
8.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End-Use, 2023 - 2030
8.7.1. Hospitals
8.7.2. Diagnostic Laboratories
8.7.3. Outpatient Clinics
8.7.4. Academic & Research Institutes
8.8. Market Attractiveness Analysis
9. Latin America Cardiac Biomarker Diagnostic Test Kits Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
9.3.1. By Country
9.3.2. By Product Type
9.3.3. By Indication
9.3.4. By End-Use
9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
9.5.1. Brain Natriuretic Peptide (BNPs) Test Kits
9.5.2. Creatine Kinase MB (CK-MB) Test Kits
9.5.3. Troponin (I&T) Tests Kits
9.5.4. Myoglobin Test Kits
9.5.5. Others
9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Indication, 2023 - 2030
9.6.1. Angina Pectoris
9.6.2. Acute Myocardial Infarction
9.6.3. Congestive Heart Failure
9.6.4. Others
9.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End-Use, 2023 - 2030
9.7.1. Hospitals
9.7.2. Diagnostic Laboratories
9.7.3. Outpatient Clinics
9.7.4. Academic & Research Institutes
9.8. Market Attractiveness Analysis
10. Middle East & Africa Cardiac Biomarker Diagnostic Test Kits Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
10.3.1. By Country
10.3.2. By Product Type
10.3.3. By Indication
10.3.4. By End-Use
10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
10.4.1. GCC
10.4.2. Egypt
10.4.3. South Africa
10.4.4. Northern Africa
10.4.5. Rest of Middle East & Africa
10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
10.5.1. Brain Natriuretic Peptide (BNPs) Test Kits
10.5.2. Creatine Kinase MB (CK-MB) Test Kits
10.5.3. Troponin (I&T) Tests Kits
10.5.4. Myoglobin Test Kits
10.5.5. Others
10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Indication, 2023 - 2030
10.6.1. Angina Pectoris
10.6.2. Acute Myocardial Infarction
10.6.3. Congestive Heart Failure
10.6.4. Others
10.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End-Use, 2023 - 2030
10.7.1. Hospitals
10.7.2. Diagnostic Laboratories
10.7.3. Outpatient Clinics
10.7.4. Academic & Research Institutes
10.8. Market Attractiveness Analysis
11. Competition Landscape
11.1. Market Share Analysis, 2022
11.2. Market Structure
11.2.1. Competition Intensity Mapping By Market
11.2.2. Competition Creatine Kinase MB (CK-MB) Test Kits
11.2.3. Apparent Product Capacity
11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
11.3.1. Abbott Laboratories
11.3.1.1. Overview
11.3.1.2. Segments and Product
11.3.1.3. Key Financials
11.3.1.4. Market Developments
11.3.1.5. Market Strategy
11.3.2. Danaher Corporation
11.3.2.1. Overview
11.3.2.2. Segments and Product
11.3.2.3. Key Financials
11.3.2.4. Market Developments
11.3.2.5. Market Strategy
11.3.3. Bio-Rad Laboratories
11.3.3.1. Overview
11.3.3.2. Segments and Product
11.3.3.3. Key Financials
11.3.3.4. Market Developments
11.3.3.5. Market Strategy
11.3.4. Thermo Fisher Scientific, Inc.
11.3.4.1. Overview
11.3.4.2. Segments and Product
11.3.4.3. Key Financials
11.3.4.4. Market Developments
11.3.4.5. Market Strategy
11.3.5. Becton, Dickinson and Company
11.3.5.1. Overview
11.3.5.2. Segments and Product
11.3.5.3. Key Financials
11.3.5.4. Market Developments
11.3.5.5. Market Strategy
11.3.6. F. Hoffmann-La Roche Ltd.
11.3.6.1. Overview
11.3.6.2. Segments and Product
11.3.6.3. Key Financials
11.3.6.4. Market Developments
11.3.6.5. Market Strategy
11.3.7. Siemens AG
11.3.7.1. Overview
11.3.7.2. Segments and Product
11.3.7.3. Key Financials
11.3.7.4. Market Developments
11.3.7.5. Market Strategy
11.3.8. BioMérieux SA
11.3.8.1. Overview
11.3.8.2. Segments and Product
11.3.8.3. Key Financials
11.3.8.4. Market Developments
11.3.8.5. Market Strategy
11.3.9. Randox Laboratories Ltd.
11.3.9.1. Overview
11.3.9.2. Segments and Product
11.3.9.3. Key Financials
11.3.9.4. Market Developments
11.3.9.5. Market Strategy
11.3.10. Others
12. Appendix
12.1. Research Methodology
12.2. Research Assumptions
12.3. Acronyms and Abbreviations
Report Sample is Available
In-depth report coverage is now just a few seconds away
Get FREE Report Sample
Make This Report Your Own
Take Advantage of Intelligence Tailored to your Business Objective
Get a Customized Version
